Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-10-15Clinical Trial Update: Beetroot Enriched Bread, Blood Pressure and Vascular Function [NA]
This completed trial evaluated whether beetroot-enriched bread affects blood pressure and vascular function in people with hypertension.
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients
This clinical trial update reports the completion of a Canadian study evaluating the effects of trandolapril on blood pressure in hypertensi…
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: The Impact of GlowCaps Connect™ and Its Services on Hypertension Medication Adherence [NA]
Completed clinical trial evaluating GlowCaps Connect and its services on adherence to hypertension medications.
-
FDA approval · 2012-10-05FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) from Novartis Pharmaceuticals Corporat…
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: Intensive Glycemic Control and Skeletal Health Study [Phase 3]
Phase 3 clinical trial update on intensive glycemic control and skeletal health; the study is completed and results were posted in 2012.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-10-05FDA Approved: GUANFACINE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s Guanfacine as an original generic application (ANDA 200881), authorizing the manufacture and marketing o…
-
FDA approval · 2012-10-04FDA Approved: DIOVAN HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Diovan HCT (valsartan and hydrochlorothiazide) submitted by Novartis Pharmaceuticals Corporation…
-
FDA approval · 2012-10-04FDA Approved: EDARBI — Supplemental Application (Azurity Pharmaceuticals, Inc.)
The FDA approved a supplemental application for EDARBI (azilsartan medoxomil) submitted by Azurity Pharmaceuticals, Inc.
-
FDA approval · 2012-10-04FDA Approved: EDARBYCLOR — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
The FDA approved a supplemental application for EDARBYCLOR, the fixed-dose combination of azilsartan medoxomil and chlorthalidone, developed…
-
FDA approval · 2012-10-03FDA Approved: IRBESARTAN — Original Application (NorthStar RxLLC)
FDA approves the original ANDA for irbesartan (IRBESARTAN) from NorthStar RxLLC as a generic version of the hypertension medicine.
-
CLINICAL_TRIALS trial_result · 2012-10-02Clinical Trial Update: An Active-controlled, Clinical Trial to Assess Central Hemodynamic Effects of Bisoprolol in Hypertensive Patients (Central Hemodynamic Assessment Measured in Patient With HypertensION [CHAMPION]) [Phase 4]
Phase 4 trial update evaluating central hemodynamic effects of bisoprolol in hypertensive patients (CHAMPION); results posted after completi…
-
CLINICAL_TRIALS trial_result · 2012-10-02Clinical Trial Update: Effectiveness of SMS Text Reminders to Improve Blood Pressure Among Patients With Hypertension [NA]
A completed clinical trial evaluating whether SMS text reminders can improve blood pressure control in patients with hypertension; results w…
-
CLINICAL_TRIALS trial_result · 2012-10-02Clinical Trial Update: To Determine Blood Pressure Interaction Between TC-5214 and Anti-Hypertensive Medications (Calcium Channel Blockers, Beta Blockers, and ACE Inhibitors) in Patients With Chronic Hypertension [Phase 1]
Phase 1 trial to determine blood pressure interactions between TC-5214 and anti-hypertensive medications in adults with chronic hypertension…
-
FDA approval · 2012-09-28FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for EXFORGE HCT, a fixed-dose combination antihypertensive (amlodipine/valsartan/hydrochlorothiazide…
-
FDA approval · 2012-09-28FDA Approved: COZAAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Cozaar (losartan potassium) filed by Organon LLC.
-
FDA approval · 2012-09-28FDA Approved: ALISKIREN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for aliskiren hemifumarate submitted by Prasco Laboratories.
-
FDA approval · 2012-09-28FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Exforge (amlodipine besylate and valsartan) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2012-09-28FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for AZOR (amlodipine besylate and olmesartan medoxomil) submitted by Cosette Pharmaceuticals, In…
-
FDA approval · 2012-09-28FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Tribenzor (olmesartan medoxomil / amlodipine besilate / hydrochlorothiazide) from Cosette Ph…
-
FDA approval · 2012-09-28FDA Approved: HYZAAR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) from Organon LLC.
-
FDA approval · 2012-09-28FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Benicar (olmesartan medoxomil) by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2012-09-27FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Dr. Reddy's to market amlodipine besylate and benazepril hydrochloride as a combination antihype…
-
FDA approval · 2012-09-27FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin's supplemental application for a generic fixed-dose combination of amlodipine besylate and benazepril hydrochloride.
-
FDA approval · 2012-09-27FDA Approved: IRBESARTAN — Original Application (Solco Healthcare U.S., LLC)
FDA approved the original application for IRBESARTAN from Solco Healthcare U.S., LLC, granting approval to market a generic version of irbes…
-
FDA approval · 2012-09-27FDA Tentative Approval: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA has issued tentative approval for Macleods Pharmaceuticals' generic fixed-dose combination of irbesartan and hydrochlorothiazide for hyp…